Molbio Diagnostics shares list 21% above IPO price on NSE

Molbio Diagnostics shares debuted at ₹980 on NSE and BSE, a 21.44% premium over the IPO price of ₹807. The ₹939.70 crore issue was subscribed 70.27 times, led by QIB demand. The company plans to use fresh issue proceeds for R&D infrastructure and manufacturing equipment, while its Truenat platform supports decentralised molecular testing.